首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

2030 年亞太地區神經刺激設備市場預測 - 區域分析 - 按產品、應用和最終用戶

市場調查報告書

商品編碼

1494500

2030 年亞太地區神經刺激設備市場預測 - 區域分析 - 按產品、應用和最終用戶

Asia Pacific Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 86 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太神經刺激設備市值為11.9794億美元，預計2030年將達到25.173億美元；預計2022年至2030年複合年成長率為9.7%。

神經刺激設備的不斷進步和批准推動亞太地區神經刺激設備市場

製造商正在投入大量資金開發先進的產品和技術，例如植入式神經刺激設備。此外，在神經刺激設備市場上，美國食品藥物管理局 (FDA) 對具有新應用的新型神經刺激器的批准有所增加。以下是神經刺激設備的一些進展和批准，2021 年 2 月，Mainstay Medical 開發了一種植入式恢復性神經刺激系統 ReActiv8，用於治療頑固性慢性下背痛。 2021 年 3 月，雅培推出了 NeuroSphere，這是一家虛擬診所，旨在幫助深度腦刺激患者在舒適的家中遠端編程和重置設備。 2021 年 1 月，波士頓科學公司發布了 WaveWriter Alpha，這是一系列脊髓刺激器 (SCS) 系統，結合了個人化疼痛緩解的治療方案。

因此，神經刺激設備的進展和批准數量的不斷增加預計將在預測期內為神經刺激設備市場提供利潤豐厚的機會。

亞太地區神經刺激設備市場概況

亞太地區神經刺激設備市場細分為中國、日本、印度、澳洲、韓國和亞太其他地區。預計亞太地區的市場將是所有地區中成長最快的。印度、澳洲和韓國等國家對神經系統疾病的認知不斷提高，決定了該地區市場的成長。由於日本和中國等國家醫療器材產業的不斷發展，亞太地區的神經刺激設備市場也有望成長。此外，神經病學的創新技術趨勢以及人工智慧（AI）和機器學習（ML）的快速採用是推動該地區市場的幾個因素。此外，政府的支持性措施和神經病學研究也促進了市場成長。

亞太地區神經刺激設備市場收入及 2030 年預測（百萬美元）

亞太地區神經刺激設備市場細分

亞太地區神經刺激設備市場根據產品、應用、最終用戶和國家進行細分。根據產品，亞太神經刺激設備市場分為脊髓刺激器、深部腦部刺激器、薦神經刺激器、迷走神經刺激器等。 2022 年，脊髓刺激器細分市場佔據最大的市場。

從應用來看，亞太神經刺激設備市場分為疼痛管理、癲癇、大小便失禁、帕金森氏症等。 2022 年，疼痛管理領域佔據最大的市場。

依最終用戶分類，亞太地區神經刺激設備市場分為醫院、專科診所等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家/地區分類，亞太地區神經刺激設備市場分為英國、中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太神經刺激設備市場佔有率中佔據主導地位。

美敦力公司 (Medtronic Plc)、波士頓科學公司 (Boston Scientific Corp)、雅培實驗室 (Abbott Laboratories)、Nevro Corp、LivaNova Plc 和 Mainstay Medical 是亞太神經刺激設備市場的領先公司。

Manufacturers are investing a significant amount in developing advanced products and technologies such as implantable neurostimulation devices. Additionally, an increase in Food and Drug Administration (FDA) approvals for novel neurostimulators with new applications are observed in the neurostimulation devices market. Following are a few advances and approvals for the neurostimulation devices, in February 2021, Mainstay Medical developed an implantable restorative neurostimulation system, ReActiv8, to treat intractable chronic low back pain. In March 2021, Abbott launched NeuroSphere, a virtual clinic designed to help deep brain stimulation patients program and reset their devices remotely from the comfort of their own homes. In January 2021, Boston Scientific Corporation released the WaveWriter Alpha, a portfolio of Spinal Cord Stimulator (SCS) systems that combine therapy options for personalized pain relief.

Therefore, the rising number of advances and approvals for neurostimulation devices is expected to provide lucrative opportunities for the neurostimulation devices market during the forecast period.

Asia Pacific Neurostimulation Devices Market Overview

The Asia Pacific neurostimulation devices market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to be the fastest growing among all the regions. The rising awareness regarding neurological disorders among countries such as India, Australia, and South Korea defines the market's growth in the region. The neurostimulation devices market in Asia Pacific is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region. Furthermore, supportive government initiatives and research in neurology also boost market growth.

Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Neurostimulation Devices Market Segmentation

The Asia Pacific neurostimulation devices market is segmented based on product, application, end user, and country. Based on product, the Asia Pacific neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Asia Pacific neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Asia Pacific neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific neurostimulation devices market is segmented into the UK, China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, and Mainstay Medical are among the leading companies operating in the Asia Pacific neurostimulation devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - Asia Pacific Market Analysis

5.1 Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Mainstay Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 8. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 12. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 22. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)